| INTRODUC TI ON
In development, the endoderm is regionalized into three types of gut components: the foregut, midgut, and hindgut. The pharynx, trachea, lungs, thyroid, esophagus, stomach, liver, and pancreas arise from the foregut. The midgut and hindgut give rise to the small intestine and colon, respectively. Intestinal epithelium is initially developed from stratified epithelium composed of a unique population of progenitor cells (designated fetal intestine-derived progenitor cells [FIPCs] ) that has no crypt-villus structures, and subsequently becoming monolayer sheets of epithelial cells with distinctive structures of villi and crypts (Madison et al., 2005) . Some signaling pathways that are essential for intestinal morphogenesis have been identified. For example, Wnt, epidermal growth factor (EGF), Notch, and bone morphogenetic protein (BMP) signaling pathways play important roles in regulating the proliferation and differentiation of intestinal epithelial cells. Wnt and EGF signaling pathways are critically required for epithelial proliferation in the intestine (Crosnier, Stamataki, & Lewis, 2006; de Santa Barbara, van den Brink, & Roberts, 2003; Lickert, Kispert, Kutsch, & Kemler, 2001; Suzuki, Sekiya, Gunshima, Fujii, & Taniguchi, 2010) . In contrast, BMP and Notch signaling pathways can control the decision of intestinal cell fate (Chin, Hill, Aurora, & Spence, 2017; de Santa Barbara et al., 2003; Yin et al., 2014) (Barker et al., 2007; Clevers, 2013; van der Flier et al., 2009; Schuijers, van der Flier, van Es, & Clevers, 2014) . The study of the properties of ISCs, FIPCs, and their progenies is required for understanding intestinal development and diseases.
| G ENER ATI ON OF MOUS E AND H UMAN INTE S TINAL ORG ANOIDS FROM PRIMARY TISSUE S
Approximately 10 years ago, a culture system for adult mouse small intestine-derived epithelial organoids was established (Sato et al., 2009 ). In these organoids, ISCs can be maintained for a long period of time under specific three-dimensional (3D) culture conditions containing EGF, noggin (an inhibitor of BMP signaling), and the Wnt agonist R-spondin1. In these culture conditions, ISCs and their progenies can build crypt-like budding structures and villus-like structures, which resemble the epithelial tissues in the intestine (right image in Figures 1 and 2a) . These ISC-derived intestinal epithelial organoids are called budding organoids (BOs), in which ISCs can produce their own cell population by self-renewal and give rise to multilineage intestinal epithelial cells (Sato et al., 2009) . Meanwhile, combinations of Wnt3a, EGF, noggin, and R-spondin1 with or without hepatocyte growth factor are required for inducing the proliferation of mouse colonic stem cells in 3D culture Yui et al., 2012) . Unlike stem cells derived from the small intestine, colonic stem cells form spherical organoids (SOs) without crypt-like structures and give rise to their progenies expressing colonic epithelial cell markers, similar to epithelial tissues in the colon Yui et al., 2012) . In addition to stem cells obtained from adult mouse-derived intestinal and colonic tissues, it is also possible to maintain FIPCs under 3D culture conditions by inducing the formation of SOs (left image in Figures 1 and 2b; Fordham et al., 2013) . Although FIPC-derived SOs contain few differentiated intestinal epithelial cell lineages, these SOs can develop into BOs as a result of serial passaging with Wnt stimulation, and subsequent removal of exogenous Wnt3a is also able to accelerate the transition of SOs into BOs (Fordham et al., 2013) . Because intestinal organoids can functionally form intestinal epithelial tissue-like structures, it is expected that these organoids could be used to investigate the development of intestinal tissues and be applied in the in vitro study of drug discovery as well as in the in vivo tissue regeneration therapies. In fact, after transplantation into the injured mouse colon, colonic SOs and FIPC-derived SOs can reconstitute colonic epithelial tissues ( Figure 2e ; Fordham et al., 2013; Yui et al., 2012) . Meanwhile, ISC-derived BOs can reconstitute crypt-villus units that resemble epithelial tissues of the small intestine after transplantation into the injured mouse colon (Figure 2e ; Fukuda et al., 2014) . Thus, it is suggested that intestinal organoids will be widely useful for not only fundamental studies in intestinal biology but also biomedical applications.
In adult humans, intestinal and colonic epithelial organoids can be generated from normal tissues under defined 3D culture conditions containing EGF, noggin, R-spondin1, Wnt3a, nicotinamide, gastrin, A83-01 (an inhibitor of ALK5), and SB202190 (an inhibitor of p38 mitogen-activated protein kinase) (Figure 2a ; Sato et al., 2011) . Also, the other group has shown that human colonic stem cells can expand by forming organoids in 3D culture with EGF, noggin, Rspondin1, Wnt3a, nicotinamide, gastrin, LY2157299 (an inhibitor of transforming growth factor beta receptor type 1 kinase), SB202190, F I G U R E 1 Representative morphologies of a spherical organoid (SO) (left image) and a budding organoid (BO) (right image) in 3D cultures of fetal and adult mouse intestinal epithelial cells, respectively. Scale bars, 100 μm F I G U R E 2 Generation of mouse and human intestinal organoids. (a) Adult mouse and human intestine-derived BOs can be generated from intestinal stem cells (ISCs) residing in the crypt base and maintained in a 3D culture containing defined factors indicated in the orange and green square, respectively. (b) Fetal intestine-derived progenitor cells (FIPCs) derived from mouse and human embryos can form SOs in a 3D culture containing EGF, noggin, and R-spondin1 with Wnt3a for mouse FIPCs or PGE-2 for human FIPCs. Subsequent removal of exogenous Wnt3a during serial passaging accelerates the development of mouse SOs into BOs. However, it is unknown whether human FIPC-derived SOs can develop into BOs in culture. (c) Human ES/iPS cell-derived HIOs can be gradually induced through the states of the DE and hindgut by adding factors required for the development of the intestine into the culture medium. (d) Using direct reprogramming technology, mouse embryonic fibroblasts (MEFs) and human umbilical vein endothelial cells (HUVECs) can be converted into iFIPCs by overexpressing Hnf4α, Foxa3, Gata6, and Cdx2, and mouse and human iFIPCs can form SOs in specific 3D culture conditions with defined factors indicated in the orange and green square, respectively. Similar to mouse FIPC-derived SOs, mouse iFIPC-derived SOs can develop into BOs during serial passaging after withdrawal of exogenous Wnt stimulation. However, similar to human FIPC-derived SOs, human iFIPC-derived SOs cannot develop into BOs even after serial passaging and withdrawal of exogenous Wnt stimulation. (e) Reconstitution of colonic and intestinal epithelial tissues after transplantation of mouse and human FIPC/iFIPC-derived SOs and mouse ISC/iISC-derived BOs, respectively, into the injured mouse colon and prostaglandin E2 (PGE-2) (Jung et al., 2011) . Moreover, a recent study showed that epithelial tissues in the injured mouse colon could be reconstituted by human colonic epithelial tissues after transplantation of adult human-derived colonic organoids (Sugimoto et al., 2018) . Meanwhile, human FIPCs are able to form SOs in culture medium containing EGF, noggin, R-spondin1, and PGE-2, although, unlike mouse FIPC-derived SOs, a culture method capable of developing human FIPCs-derived SOs into BOs remains to be established (Figure 2b ; Fordham et al., 2013) . Recent progress directed at clinical applications using organoids enabled the generation of a colorectal cancer organoid model using healthy human-derived colonic organoids and the correction of a mutation within the colonic epithelial cells obtained from patients with hereditary diseases using a gene editing technology in a 3D organoid culture (Dekkers et al., 2013; Drost et al., 2015 Drost et al., , 2017 Matano et al., 2015) . Thus, the medical application of human tissue-derived organoids is clearly moving forward.
| G ENER ATI ON OF H UMAN INTE S TINAL ORG ANOIDS FROM PLURIP OTENT S TEM CELL S
In a paper published in 2011, a method for generating human intestinal organoids (HIOs) from pluripotent stem cells (PSCs), such as embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, has been reported (Spence et al., 2011) . HIOs can be gradually induced from PSCs by adding several essential factors into the culture medium for the development of the intestine (Figure 2c) . Initially, PSCs can differentiate into cells comprising the definitive endoderm (DE) by the effect of activin A. Then, the hindgut is induced from the DE in culture medium containing fibroblast growth factor 4 (FGF4) and Wnt3a, and the development of the hindgut into intestinal tissues can be induced in 3D culture with EGF, noggin, and R-spondin1. HIOs have some crypt-villus structures and contain cells expressing marker genes for ISCs and intestinal epithelial cell lineages. However, it is also known that HIOs are still immature and lack some specific features of adult intestine in the absence of long-term culture or transplantation (Finkbeiner et al. 2015; Sinagoga & Wells, 2015) . Interestingly, HIOs are composed of not only epithelial cells, but also mesenchymal cells, including fibroblasts and smooth muscle cells (Spence et al., 2011) . In intestinal development, epithelial-mesenchymal interaction is important for the proliferation and differentiation of both epithelial and mesenchymal cells in intestinal tissues (Powell, Pinchuk, Saada, Chen, & Mifflin, 2011) . Thus, PSC-derived HIOs could be useful for the study of mechanisms controlling human intestinal development.
| G ENER ATI ON OF MOUS E AND H UMAN INTE S TINAL ORG ANOIDS US ING D IREC T REPROG R AMMING TECHNOLOGY
In addition to the generation of intestinal organoids from intestinal tissue fragments and PSCs, direct reprogramming technology can also be useful as the third protocol for the generation of intestinal organoids. This new technology enables the conversion of differentiated somatic cells into other cell types without undergoing the pluripotent state. For example, myoblasts, neurons, cardiomyocytes, and hepatocytes can be generated directly from fibroblasts using this technology (Davis, Weintraub, & Lassar, 1987; Huang et al., 2011; Ieda et al., 2010; Sekiya & Suzuki, 2011; Vierbuchen et al., 2010) . In our previous study, mouse embryonic fibroblasts (MEFs) could be converted into induced FIPC (iFIPCs) following the overexpression of the defined transcription factors hepatocyte nuclear factor 4 alpha (Hnf4α), forkhead box protein A3 (Foxa3), GATA-binding factor 6 (Gata6), and caudal-related homeobox protein 2 (Cdx2) in MEFs (Figure 2d ; Miura & Suzuki, 2017) . Similar to 
| CON CLUS ION
As described above, the protocols used for the culture of FIPCs/ ISCs allow us to generate intestinal organoids from several types of cells, including intestinal tissue-derived cells, ES/iPS cells, and MEFs/ HUVECs infected with defined transcription factors, which may be useful in the study of intestinal development and applications toward drug screening and regenerative therapy. We will be able to choose the best source of cells in accordance with the purposes of use. 
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